All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication. 2007

Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
Department of Hematology, Kinki University School of Medicine, Osaka, Japan. ymaeda@med.kindai.ac.jp

We previously reported that all-trans retinoic acid (ATRA) inhibited growth in HTLV-1-positive T-cell lines and fresh cells from patients with adult T-cell leukemia. Interestingly, ATRA significantly inhibited reverse transcriptase (RT) activity similar to azidothimidine (AZT) in HTLV-1-positive T-cell lines. To clarify whether ATRA has an inhibitory effect on the replication of HIV, we examined HIV proviral DNA in a HIV-1-positive cell line (8E5) using real time PCR. ATRA as well as AZT reduced the proviral DNA load of 8E5 in a dose-dependent manner. These results suggest that there is a common element of ATRA signaling in both HTLV-1 and HIV. Furthermore, we examined the effects of ATRA on viral replication in primary lymphocytes of three individuals infected with HIV. ATRA reduced viral replication significantly similar to AZT. These findings suggested that ATRA acts as a RT inhibitor, reducing the HIV-1 proviral DNA load. Finally, we conclude that ATRA may be a potential therapeutic agent for HIV infection.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
December 1990, Science (New York, N.Y.),
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
January 2002, Planta medica,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
September 2012, Physical chemistry chemical physics : PCCP,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
January 1995, The Journal of the Association of Physicians of India,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
February 2013, Molecular therapy. Nucleic acids,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
April 2004, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
March 1981, The Journal of investigative dermatology,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
July 2007, International journal of pharmaceutics,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
April 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Yasuhiro Maeda, and Terufumi Yamaguchi, and Yasuki Hijikata, and Yasuyoshi Morita, and Miyako Tanaka, and Chikara Hirase, and Shunsuke Takai, and Yoichi Tatsumi, and Akihisa Kanamaru
September 1992, European journal of haematology,
Copied contents to your clipboard!